Velavan Bakthavachalam

Statistics

Publications

Citations

103

H-Index

Active since

2020

Affiliations

University of Illinois Chicago, Rockford campus(Current)

Velavan Bakthavachalam is an author at University of Illinois Chicago, Rockford campus specializing in oncology, pharmacology, and apoptotic signaling in cancer.

Publications per year

2020–2020

Publications

Neferine, an alkaloid from lotus seed embryo targets <scp>HeLa</scp> and <scp>SiHa</scp> cervical cancer cells via pro‐oxidant anticancer mechanism

Subramanyam Dasari, Velavan Bakthavachalam, Somaiah Chinnapaka et al. · Phytotherapy Research · 2020 · 46 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Repurposing antidepressant sertraline as a pharmacological drug to target prostate cancer stem cells: dual activation of apoptosis and autophagy signaling by deregulating redox balance.

Somaiah Chinnapaka, Velavan Bakthavachalam, Gnanasekar Munirathinam · PubMed · 2020 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis

Angela Lincy Prem Antony Samy, Velavan Bakthavachalam, Mona Vudutha et al. · Toxicology and Applied Pharmacology · 2020 · 12 citations · Full text

Medicine, Oncology, Pharmacology +13

1–3 of 3